Anastasios E Germenis
Overview
Explore the profile of Anastasios E Germenis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuraw B, Bork K, Bouillet L, Christiansen S, Farkas H, Germenis A, et al.
Clin Rev Allergy Immunol
. 2025 Mar;
68(1):24.
PMID: 40053270
Hereditary angioedema (HAE) has been recognized for almost 150 years. The newest form of HAE, where C1 inhibitor levels are normal (HAE-nC1INH), was first described in 2000. Over the last...
2.
Kapousouzi A, Kalala F, Sarrou S, Farmaki E, Antonakos N, Kakkas I, et al.
Medicina (Kaunas)
. 2024 May;
60(5).
PMID: 38792965
: Predominantly antibody deficiencies (PAD) represent the most common type of primary immunodeficiencies in humans, characterized by a wide variation in disease onset, clinical manifestations, and outcome. Considering that the...
3.
Vincent D, Parsopoulou F, Martin L, Gaboriaud C, Demongeot J, Loules G, et al.
J Allergy Clin Immunol Glob
. 2024 Mar;
3(2):100223.
PMID: 38445235
Background: Hereditary angioedema (HAE) is a potentially life-threatening disorder characterized by recurrent episodes of subcutaneous or submucosal swelling. HAE with normal C1 inhibitor (HAE-nC1-INH) is an underdiagnosed condition. Although the...
4.
Karamanakos A, Vougiouka O, Sapountzi E, Venetsanopoulou A, Tektonidou M, Germenis A, et al.
Front Immunol
. 2024 Feb;
15:1342668.
PMID: 38348033
Objective: To assess the impact conferred by variants on the clinical spectrum of patients with systemic autoinflammatory diseases (SAIDs) in Greece. Methods: Consecutive patients (n=167) with confirmed SAIDs who underwent...
5.
Lyons J, Farkas H, Germenis A, Rijavec M, Smith T, Valent P
J Allergy Clin Immunol Pract
. 2023 Jun;
11(8):2286-2301.
PMID: 37263349
Advances in next generation sequencing technologies, as well as their expanded accessibility and clinical use over the past 2 decades, have led to an exponential increase in the number of...
6.
Farkas H, Germenis A, Longhurst H
Front Allergy
. 2022 Nov;
3:1065400.
PMID: 36439023
No abstract available.
7.
Zamanakou M, Vatsiou S, Batsaki P, Fortis S, Germenis A
HLA
. 2022 Nov;
101(5):555-557.
PMID: 36437488
We report here the identification by next-generation sequencing of a novel HLA allele, DRB1*11:308, in a Greek individual as a part of a research project investigating diagnostic and prognostic biomarkers...
8.
Drouet C, Lopez-Lera A, Ghannam A, Lopez-Trascasa M, Cichon S, Ponard D, et al.
Front Allergy
. 2022 Aug;
3:835503.
PMID: 35958943
Hereditary angioedema with C1 Inhibitor deficiency (C1-INH-HAE) is caused by a constellation of variants of the gene ( = 809; 1,494 pedigrees), accounting for 86.8% of HAE families, showing a...
9.
Parsopoulou F, Loules G, Zamanakou M, Csuka D, Szilagyi A, Kompoti M, et al.
Front Allergy
. 2022 Jul;
3:868185.
PMID: 35873600
Existing evidence indicates that modifier genes could change the phenotypic outcome of the causal variant and thus explain the expression variability of hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE). To...
10.
Latsoudis H, Stylianakis E, Mavroudi I, Kanterakis A, Pavlidis P, Georgopoulou A, et al.
Cytotherapy
. 2021 Sep;
24(2):183-192.
PMID: 34465516
Background Aims: The high genetic diversity of HLA across populations significantly confines the effectiveness of a donor or umbilical cord blood search for allogeneic hematopoietic stem cell transplantation (HSCT). This...